@myjiggers1
Stacy,
I found this, idk if it helps

“ JUNE 4, 2025
Natera Announces Medicare Coverage for Signatera™ Genome
Broad coverage, inclusive of all previously covered Signatera indications
AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its genome-based Signatera MRD assay is now covered by Medicare under LCD L38779.
This coverage decision applies to Medicare beneficiaries with colorectal cancer, breast cancer, bladder cancer, ovarian cancer, lung cancer, and pan-cancer immunotherapy monitoring, mirroring the pre-existing coverage for Signatera.
The coverage determination was supported by robust evidence on the validity of the genome-based assay, leveraging the extensive body of literature validating Signatera in over 100 published clinical studies.”
Hugs!🤗
Good luck in your appointment!🍀💗